Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for AbbVie, Inc. > News item |
JPMorgan to price trigger phoenix autocallables linked to AbbVie
By Wendy Van Sickle
Columbus, Ohio, Dec. 3 – JPMorgan Chase & Co. plans to price trigger phoenix autocallable optimization securities due Dec. 10, 2020 linked to the common stock of AbbVie, Inc., according to an FWP filed with the Securities and Exchange Commission.
If AbbVie stock closes at or above the trigger price, 58% to 64% of the initial share price, on a monthly observation date, the issuer will pay a contingent coupon for that month at the rate of 8% per year. Otherwise, no coupon will be paid that month. The exact trigger price will be set at pricing.
Beginning Dec. 5, 2016, the notes will be called at par of $10 plus the contingent coupon if the shares close at or above the initial price on any monthly observation date.
If the notes are not called and AbbVie shares finish at or above the trigger price, the payout at maturity will be par plus the contingent coupon. Otherwise, investors will be exposed to the share price decline from the initial price.
UBS Financial Services Inc. and J.P. Morgan Securities LLC are the agents.
The notes will price on Dec. 4 and settle on Dec. 9.
The Cusip number is 48128A707.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.